'Pharma bro' Martin Shkreli seeks revenge against rival drug companies with scathing new website
Hedge fund manager-turned-drug exec Martin Shkreli (Twitter)

Martin Shkreli is tired of being pharma's favorite scapegoat. Shkreli, the former drug company CEO who rocketed to notoriety when he hiked the price of an old drug by 5,000 percent, routinely gets blamed by other pharma CEOs for tarnishing the reputation of the entire industry. On Monday, the trade group PhRMA launched a new multi-million…